Medicare Enrolled
Dr. Carlos Tejeda, M.D.
Internal Medicine · Passaic, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tejeda from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tejeda?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tejeda
Dr. Carlos Tejeda is an internal medicine specialist in Passaic, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Tejeda performed 1,172 Medicare services across 774 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tejeda received a total of $10,756 from 67 pharmaceutical and/or device companies across 692 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tejeda is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 40% volume in NJ
$10,756 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,172
Medicare services
Top 40% in NJ for internal medicine
774
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~59 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
318 | $99 | $225 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
136 | $50 | $70 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
109 | $3 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
96 | $64 | $150 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
83 | $142 | $250 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
65 | $12 | $75 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
63 | $34 | $40 |
| Annual depression screening | 61 | $20 | $41 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
49 | $66 | $150 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
33 | $22 | $50 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
19 | $93 | $175 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
18 | $154 | $300 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $95 | $273 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
18 | $244 | $500 |
| Developmental testing with interpretation and report A standardized assessment to evaluate a patient's developmental progress. The service includes performing the test, interpreting the results, and providing a written report. |
18 | $8 | $50 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
17 | $72 | $125 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
14 | $46 | $144 |
| Annual alcohol misuse screening, 5 to 15 minutes | 14 | $21 | $40 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 12 | $239 | $350 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
11 | $66 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,756
Total received (2018-2024)
Avg $1,537/year across 7 years
Top 7% in NJ for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
692
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,744 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,445
2023
$1,180
2022
$1,706
2021
$1,695
2020
$1,044
2019
$1,835
2018
$1,851
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$629
Stryker Corporation
$124
Novo Nordisk Inc
$102
PFIZER INC.
$81
Amgen Inc.
$79
Novartis Pharmaceuticals Corporation
$63
Lilly USA, LLC
$55
Exact Sciences Corporation
$51
GlaxoSmithKline, LLC.
$48
Otsuka America Pharmaceutical, Inc.
$33
Teva Pharmaceuticals USA, Inc.
$33
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$31
Xeris Pharmaceuticals, Inc.
$17
Lundbeck LLC
$17
Gilead Sciences, Inc.
$17
Merck Sharp & Dohme LLC
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Phathom Pharmaceuticals, Inc.
$15
Neos Therapeutics, LP
$15
Top 3 companies account for 59.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,617
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,070
Novo Nordisk Inc
$876
Amgen Inc.
$871
Merck Sharp & Dohme Corporation
$481
PFIZER INC.
$398
Lilly USA, LLC
$393
SANOFI-AVENTIS U.S. LLC
$356
GlaxoSmithKline, LLC.
$353
Novartis Pharmaceuticals Corporation
$307
AbbVie Inc.
$263
Boston Scientific Corporation
$260
Amarin Pharma Inc.
$243
Sunovion Pharmaceuticals Inc.
$216
Bayer HealthCare Pharmaceuticals Inc.
$210
ABBVIE INC.
$199
MannKind Corporation
$182
Ironwood Pharmaceuticals, Inc
$135
Stryker Corporation
$124
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$117
Bayer Healthcare Pharmaceuticals Inc.
$104
Dynavax Technologies Corporation
$101
ABIOMED
$100
Allergan, Inc.
$95
Medtronic Vascular, Inc.
$92
Otsuka America Pharmaceutical, Inc.
$92
Biogen, Inc.
$91
Allergan Inc.
$84
Teva Pharmaceuticals USA, Inc.
$82
Mylan Specialty L.P.
$64
Corcept Therapeutics
$64
Radius Health, Inc.
$54
Exact Sciences Corporation
$51
Takeda Pharmaceuticals U.S.A., Inc.
$49
Merck Sharp & Dohme LLC
$47
Gilead Sciences, Inc.
$46
SANOFI PASTEUR INC.
$45
Janssen Pharmaceuticals, Inc
$45
Avanir Pharmaceuticals, Inc.
$44
Synergy Pharmaceuticals Inc
$44
Mannkind Corporation
$43
Valeritas, Inc.
$43
Horizon Therapeutics plc
$42
Vanda Pharmaceuticals Inc.
$41
Abbott Laboratories
$40
RedHill Biopharma Inc.
$38
ALK-Abello, Inc
$36
Azurity Pharmaceuticals, Inc.
$35
Xeris Pharmaceuticals, Inc.
$31
Neos Therapeutics, LP
$29
Nestle HealthCare Nutrition Inc.
$28
Genentech USA, Inc.
$28
Purdue Pharma L.P.
$27
IRONWOOD PHARMACEUTICALS, INC
$26
Sanofi Pasteur Inc.
$26
Althera Pharmaceuticals LLC
$17
Lundbeck LLC
$17
Evoke Pharma, Inc.
$16
Phathom Pharmaceuticals, Inc.
$15
BioCryst US Sales Co., LLC
$15
Kowa Pharmaceuticals America, Inc.
$15
Becton, Dickinson and Company
$15
VBI Vaccine (Delaware) Inc.
$15
SUN PHARMACEUTICAL INDUSTRIES INC.
$14
Almatica Pharma LLC
$12
Zealand Pharma US, Inc.
$12
Eisai Inc.
$12
Top 3 companies account for 33.1% of all-time payments
Associated products mentioned in payments ›
ABRYSVO · ADUHELM · AFREZZA · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AUSTEDO · Adzenys XR-ODT · Aimovig · Amitiza · Austedo XR · BASAGLAR · BD Ultra-Fine · BELSOMRA · BREZTRI · BYSTOLIC · Belviq · CHANTIX · CIBINQO · COLOGUARD DNA CAPTURE REAGENTS · CREON · Cologuard Collection Kit · DUEXIS · DULERA · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FANAPT · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT · FREESTYLE LIBRE · FreeStyle Libre 2 · GARDASIL · GEMTESA · GIMOTI · GRALISE · GVOKE HYPOPEN · GVOKE PFS · HETLIOZ · HUMIRA · Heplisav-B · IMFINZI · INVOKANA · Impella · JANUVIA · JARDIANCE · KAPSPARGO · Kerendia · Korlym · LATUDA · LEQVIO · LINZESS · LOKELMA · LONHALA MAGNAIR · Linzess · Livalo · MAKO · MOUNJARO · Mosaic · Movantik · NUEDEXTA · NURTEC ODT · Nuedexta · ORLADEYO · Odactra · Otezla · Ozempic · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PRADAXA · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PreHevbrio · Prolia · QULIPTA · REXULTI · RYBELSUS · Repatha · Roszet · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · SYNTHROID · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · Trulance · Tymlos · UBRELVY · UTIBRON · Utibron · V-GO · VOQUEZNA · VRAYLAR · Vascepa · Victoza · WATCHMAN · WATCHMAN Access System · Wegovy · XARELTO · XIFAXAN · XIGDUO · Xofluza · Yupelri · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for internal medicine in NJ.
Geographic Context
Internal medicine physicians within 10 mi
10,742
Per 100K population
2072.6
County median income
$87,137
Nearest hospital
ST MARY'S GENERAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tejeda is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 7% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tejeda experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Tejeda performed 318 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tejeda receive payments from pharmaceutical companies?
Yes. Dr. Tejeda received a total of $10,756 from 67 companies across 692 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tejeda's costs compare to other internal medicine physicians in Passaic?
Dr. Tejeda's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tejeda) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Passaic
Browse internal medicine physicians in Passaic ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in NJ
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in NJ
Which NJ internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology